IMVT: Venker Eric discloses securities transactions

By AlphaYouPublished Oct 5, 2026Form 4

Stocks in this disclosure

Reported activity

Venker Eric

Reporting filer

Venker Eric reported Exercise or conversion in Immunovant, Inc.: 92187 units of Common Stock, dated 2026-10-01. The full Form 4 contains 4 transaction entries.

Disclosed: Oct 5, 2026

Reported details

4 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Venker Eric	2026-10-01	M	Exercise or conversion	92187	14.46	346,467	4 days	Filed terms security Title: Common Stock transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: M equity Swap Involved: 0 id: F1 id: F2 transaction Shares: 92187 id: F1 id: F2 transaction Price Per Share: 14.46 id: F1 id: F2 transaction Acquired Disposed Code: A shares Owned Following Transaction: 346467 direct Or Indirect Ownership: D
Common Stock	Venker Eric	2026-10-01	D	Disposition to issuer	85886	33.65	260,581	4 days	Filed terms security Title: Common Stock transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: D equity Swap Involved: 0 id: F1 id: F2 transaction Shares: 85886 id: F1 id: F2 transaction Price Per Share: 33.65 id: F1 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 260581 direct Or Indirect Ownership: D
Common Stock	Venker Eric	2026-10-02	S	Sale	3506	34.11	257,075	3 days	Filed terms security Title: Common Stock transaction Date: 2026-10-02 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F3 transaction Shares: 3506 transaction Price Per Share: 34.11 transaction Acquired Disposed Code: D shares Owned Following Transaction: 257075 direct Or Indirect Ownership: D
Capped Value Appreciation Rights (derivative)	Venker Eric	2026-10-01	M	Exercise or conversion	92187	0	921,875	4 days	Filed terms security Title: Capped Value Appreciation Rights conversion Or Exercise Price: 14.46 id: F1 id: F2 transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: M equity Swap Involved: 0 id: F1 id: F2 transaction Shares: 92187 id: F1 id: F2 transaction Price Per Share: 0 transaction Acquired Disposed Code: D id: F2 id: F4 expiration Date: 2030-04-01 underlying Security Title: Common Stock underlying Security Shares: 92187 id: F1 id: F2 shares Owned Following Transaction: 921875 direct Or Indirect Ownership: D

Common Stock

Owner: Venker Eric
Date: 2026-10-01
Code: M
Action: Exercise or conversion
Quantity: 92187
Price: 14.46
Following holdings: 346,467
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: M
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 92187
id: F1
id: F2
transaction Price Per Share: 14.46
id: F1
id: F2
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 346467
direct Or Indirect Ownership: D

Common Stock

Owner: Venker Eric
Date: 2026-10-01
Code: D
Action: Disposition to issuer
Quantity: 85886
Price: 33.65
Following holdings: 260,581
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: D
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 85886
id: F1
id: F2
transaction Price Per Share: 33.65
id: F1
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 260581
direct Or Indirect Ownership: D

Common Stock

Owner: Venker Eric
Date: 2026-10-02
Code: S
Action: Sale
Quantity: 3506
Price: 34.11
Following holdings: 257,075
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-02
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F3
transaction Shares: 3506
transaction Price Per Share: 34.11
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 257075
direct Or Indirect Ownership: D

Capped Value Appreciation Rights (derivative)

Owner: Venker Eric
Date: 2026-10-01
Code: M
Action: Exercise or conversion
Quantity: 92187
Price: 0
Following holdings: 921,875
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Capped Value Appreciation Rights
conversion Or Exercise Price: 14.46
id: F1
id: F2
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: M
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 92187
id: F1
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F4
expiration Date: 2030-04-01
underlying Security Title: Common Stock
underlying Security Shares: 92187
id: F1
id: F2
shares Owned Following Transaction: 921875
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Venker Eric: Chief Executive Officer, Director.
F1: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.
F2: On October 1, 2026, the Service Requirement (as defined in Footnote 4), Performance Requirement (as defined in Footnote 4), Knock-In Requirement (as defined in Footnote 4), and hurdle price applicable to 92,187 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on October 1, 2026.
F3: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F4: These CVARs vest on the first date that each of (i) the Service Requirement, (ii) the Performance Requirement, and (iii) the Knock-in Requirement have been satisfied. The "Service Requirement" is satisfied as follows: (i) 25% of the CVARs vested on April 1, 2026; and (ii) the remaining 75% vests in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer or an affiliate on each such vesting date. The "Performance Requirement" is tied to the achievement of a specified clinical development activity at the Issuer, which requirement was met as of March 31, 2026. The "Knock-in Requirement" requires that the price of the Issuer's common stock at each applicable vesting date must be equal to or greater than $16.76 per share.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Venker Eric

2026-10-01

Exercise or conversion

92187

14.46

346,467

4 days

Filed terms

security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: M
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 92187
id: F1
id: F2
transaction Price Per Share: 14.46
id: F1
id: F2
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 346467
direct Or Indirect Ownership: D

Common Stock

Venker Eric

2026-10-01

Disposition to issuer

85886

33.65

260,581

4 days

Filed terms

security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: D
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 85886
id: F1
id: F2
transaction Price Per Share: 33.65
id: F1
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 260581
direct Or Indirect Ownership: D

Common Stock

Venker Eric

2026-10-02

Sale

3506

34.11

257,075

3 days

Filed terms

security Title: Common Stock
transaction Date: 2026-10-02
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F3
transaction Shares: 3506
transaction Price Per Share: 34.11
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 257075
direct Or Indirect Ownership: D

Capped Value Appreciation Rights (derivative)

Venker Eric

2026-10-01

Exercise or conversion

92187

921,875

4 days

Filed terms

security Title: Capped Value Appreciation Rights
conversion Or Exercise Price: 14.46
id: F1
id: F2
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: M
equity Swap Involved: 0
id: F1
id: F2
transaction Shares: 92187
id: F1
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: D
id: F2
id: F4
expiration Date: 2030-04-01
underlying Security Title: Common Stock
underlying Security Shares: 92187
id: F1
id: F2
shares Owned Following Transaction: 921875
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Venker Eric: Chief Executive Officer, Director.

F1: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date.

F2: On October 1, 2026, the Service Requirement (as defined in Footnote 4), Performance Requirement (as defined in Footnote 4), Knock-In Requirement (as defined in Footnote 4), and hurdle price applicable to 92,187 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on October 1, 2026.

F3: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F4: These CVARs vest on the first date that each of (i) the Service Requirement, (ii) the Performance Requirement, and (iii) the Knock-in Requirement have been satisfied. The "Service Requirement" is satisfied as follows: (i) 25% of the CVARs vested on April 1, 2026; and (ii) the remaining 75% vests in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer or an affiliate on each such vesting date. The "Performance Requirement" is tied to the achievement of a specified clinical development activity at the Issuer, which requirement was met as of March 31, 2026. The "Knock-in Requirement" requires that the price of the Issuer's common stock at each applicable vesting date must be equal to or greater than $16.76 per share.